Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biontech Se ADR
(NQ:
BNTX
)
88.22
+0.62 (+0.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biontech Se ADR
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
63
64
Next >
Menstrual Irregularities Cases After mRNA COVID-19 Vaccine - EMA Reviews Cases
February 11, 2022
The European Medicines Agency's safety committee is reviewing reports of heavy menstrual bleeding and absence of menstruation after COVID-19 vaccines from ...
Via
Benzinga
Two Insider Moonshots Rising on Sudden Buying
February 10, 2022
Biotech insiders are among the most important investors to pay close attention to. Here are two that show good signs for the future.
Via
InvestorPlace
US Plans COVID-19 Vaccine Roll Out For Kids Under 5 Years This Month
February 10, 2022
The U.S. government is planning a COVID-19 vaccine roll out for children under the age of 5 as soon as February 21, according to a document from the U.S.
Via
Benzinga
Novavax Tumbles On Reports Of Underdelivering COVID-19 Vaccine Commitments
February 08, 2022
Novavax, Inc. (NASDAQ: NVAX) shares are tumbling Tuesday on a negative headline concerning the Maryland-based biopharma's COVID-19 vaccine.
Via
Benzinga
Pfizer Could Soon Be A $100 Billion Company — Why It Might Not Be Enough
February 08, 2022
Pfizer's fourth-quarter sales skyrocketed, but not enough to meet expectations.
Via
Investor's Business Daily
Could This Be A Potential New Weapon In The Fight Against COVID-19?
February 01, 2022
Photo by Mufid Majnun on Unsplash
Via
Benzinga
New Study Suggests Omicron Booster Isn't Needed — And Moderna Dips
February 07, 2022
A test found Moderna's booster and an omicron booster performed similarly in monkeys.
Via
Investor's Business Daily
Cathie Wood's Ark Invest Sheds Stake In This Large-Cap Pharma Ahead Of Earnings
February 05, 2022
Big pharma reporting season was muted, with the quarterly results and guidance coming in mixed.
Via
Benzinga
Germany's Vaccine Commission Recommends Novavax's COVID-19 Vaccine For Adults: Reuters
February 04, 2022
Germany's expert panel on vaccine use has recommended Novavax Inc's (NASDAQ:
Via
Benzinga
7 Hot Stocks That Can Win in Either a Bull or Bear Market
February 04, 2022
In today’s hyper-sensitive market, investors are searching for those defensive hot stocks that can weather all storms.
Via
InvestorPlace
Avoid Novavax for Now, Until the Picture Clears Up
February 02, 2022
NVAX stock may have seen a near-term bounce following the completion of filing of EUA filing with the FDA, but it may not be a buy yet.
Via
InvestorPlace
FDA Asks Pfizer - BioNTech To Submit For COVID-19 Vaccine Emergency Use Nod For Youngest Children
February 02, 2022
Pfizer Inc (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) have
Via
Benzinga
A Peek Into The Markets: US Stock Futures Edge Lower Following Monday's Surge; Alphabet Earnings in Focus
February 01, 2022
Pre-open movers
Via
Benzinga
Pfizer Could Seek COVID-19 Vaccine Emergency Approval For Children Under 5 This Week
January 31, 2022
Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) are likely to submit a request for an emergency use authorization to the U.S.
Via
Benzinga
Novavax: The Fall of a Covid-19 Vaccine Star
January 31, 2022
Novavax is finally starting to deliver effective Covid-19 vaccines in quantity around the world, but investors have moved on from NVAX stock.
Via
InvestorPlace
Will Moderna Sidestep The Looming Sales Cliff After FDA Approves Covid Shot?
January 31, 2022
Currently, analysts expect Moderna sales to drop off after 2022.
Via
Investor's Business Daily
A Look Into Healthcare Sector Value Stocks
January 31, 2022
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
After Pfizer, Moderna Kickstarts Omicron-Targeted COVID-19 Vaccine Trial
January 27, 2022
Moderna Inc (NASDAQ: MRNA) has started a mid-stage study, testing a booster dose of its COVID-19 vaccine specifically
Via
Benzinga
Uncertain Market Conditions And Good News Make Novavax A Cautious Buy
January 25, 2022
An emergency use authorization in Australia is the latest example of the “yeah but” narrative that has plagued NVAX stock for the past year.
Via
InvestorPlace
What Are Whales Doing With BioNTech
January 25, 2022
Someone with a lot of money to spend has taken a bearish stance on BioNTech (NASDAQ:BNTX). And retail traders should know. We noticed this today when the big position showed up on...
Via
Benzinga
BNTX Stock Alert: The Omicron Vaccine News That Has BioNTech Shooting Higher Today
January 25, 2022
BioNTech (BNTX) stock is rising higher on news it and Pfizer (PFE) can test a new Covid-19 vaccine for Omicron in adults.
Via
InvestorPlace
Pfizer, BioNTech Launch Omicron-Targeted COVID-19 Vaccine Trial
January 25, 2022
Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have started a clinical trial to test a new version of their vaccine specifically designed to target...
Via
Benzinga
The U.S. Stock Market Continues To Be In A Sell-Off
January 25, 2022
Yesterday, major US stock indices showed a sharp decline throughout the trading day, but at the end of the trading session recovered their positions sharply and closed in the green territory.
Via
Talk Markets
The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data
January 25, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Pfizer, BioNTech Initiates Study Of Omicron-Based Vaccine Candidate Pfizer,...
Via
Benzinga
Markets Fears
January 24, 2022
Today markets dropped precipitously over fear of a Ukrainian invasion and higher interest rates and inflation.
Via
Talk Markets
Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows
January 24, 2022
A third booster dose of a COVID-19 vaccine from either AstraZeneca Plc (NASDAQ: AZN), Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ: BNTX), or ...
Via
Benzinga
A Bearish Sign Appears On BioNTech's Chart
January 24, 2022
If history is any guide, there may be trouble ahead for shares of BioNTech (NASDAQ:BNTX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be...
Via
Benzinga
Arcturus Therapeutics' COVID-19 Booster Clinical Trial Show Encouraging Neutralizing Antibody Responses
January 24, 2022
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) has announced updated data Phase 1/2 booster trial of ARCT-154 and ARCT-165, its investigational, self-amplifying...
Via
Benzinga
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
63
64
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.